Cycloserine

Cycloserine cyclosporin cyclosporin cyclosporin cyclosporin 100mg ml soln.

A total of 24 chronic cases are still under onset of the study four continued to receive with cycloserine, but these were subsequently sence of apparent advantages over cycloserine and five females, aged 24 to 84 years, of negroes, and nine puerto ricans. Transportation exhilarating and safe; it provides communication and information anywhere, anytime; and it provides entertainment a home away from home ; . He expects more wireless choices in the future. Intel sponsored the food, drink, and networking at Comerica Park and the baseball game. ITS Michigan Executive Director Frank Cardimen guaranteed at Tiger victory, and Tiger pitcher Kenny Rogers delivered that victory. On the second day Tammi Shepard described the "Wireless Oakland" project, and Uma Harithsa described the "Wireless Washtenaw" project. Mia Silver from MDOT discussed the use of ITS technologies in managing the traffic operations for the All-Star Baseball game and Super Bowl XL. Dynamic messages signs were one of the tools used to direct traffic for these events. David Henry from Daimler-Chrysler described the DCX test bed for VII in Auburn Hills. There will be 2800 vehicles transmitting information by the end of 2006. Ralph Robinson from Ford Motor, President of the VII Consortium, described the National VII Consortium project. The nine key use cases are Electron Brake light Warning, Signal Violation Warning, In-vehicle Signage, Dynamic Traffic Information, Roadway Conditions, Traffic Management and Control, Alternative Route Guidance, Payment Transactions, and Provisioning and Security Management. The Proof of Concept will be in Southeast Michigan. Susette Peplinski, the MDOT Grand Region Operations Engineer, provided an overview of ITS operations in the Grand Rapids area. Twenty-three miles of I-96 and I-196 are instrumented. The Traffic Operations Center operates during weekday peak hours and summer peak hours. The center provides the Michigan State Police, Grand Rapids Police, and TV stations with camera feeds from the closed circuit television cameras on the freeways. One-hour treatments, totaling anywhere from , 500 to , 500, to deforest a bikini line. These results, however, are permanent ; . But not everyone is a candidate for laser hair removal. Those with the greatest contrast between hair and skin color are ideal, which means that Caucasians who are natural blondes or redheads, or have white or gray hair, may benefit less from the treatment while brunettes wiith fair, untanned skin get the best results. "A light is shined on the skin, but it's absorbed only where there's pigment, " said laser dermatologist Melanie Grossman, M.D., explaining how the laser works. "Think of how a dark car or dark shirt on a sunny day gets really hot. The light turns to heat, and the heat is located only where there's a pigmented hair. That's the way the laser selectively destroys the target." Newer lasers, however, can zero in even on dark-haired, darkskinned types. Robert Guida, M.D., an Upper East Side plastic surgeon, has been using a machine called Lyra since last summer, and he says that since then, he has developed a large following of AfricanAmericans seeking laser hair removal. In addition, the machine is the first and only FDA-approved treatment for razor bumps, a condition afflicting black skin in particular. Anyone who has read the advertisements inside a public bus or in the backs of magazines these days has probably realized that the proliferation of laser hair-removal centers is to the new millennium what Korean nail salons were to the late eighties. But just because a manicurist is qualified to wield a cuticle clipper doesn't mean she should pick up a laser. The regulations for the practice of laser hair removal vary from state to state. For instance, in New Jersey the procedure must be performed by a physician, whereas in Connecticut and California it may be administered by a licensed health-care professional under the direct supervision of a doctor; New York requires only that a doctor be at the facility. Dermatologists argue that their knowledge of skin and ability to diagnose and treat hormonal problems that may cause abnormal hair growth, not to mention the complications that can result from laser hair removal, like pigment changes, blistering, and scarring, make them better qualified than nonphysicians to perform the procedure. David J. Goldberg, M.D., J.D., a dermatologist and lawyer in both Manhattan and New Jersey, advises that anyone interested in laser hair removal ask the practitioner at least the following questions: How long have you been doing this? Who supervises you? And do you use one machine for everyone? Remember: Not all lasers can treat dark skin.

In bacteria, such regions have been shown to be particularly prone to replication slippage Levinson and Gutman 1987 ; . It has been shown earlier that direct repeats contribute significantly to variability of plastid chromosomes even between closely related species Aldrich et al. 1988; Wolfe, Morden, and Palmer 1992 ; . Coding Regions are Highly Conserved Between Atropa and Tobacco As an important interface in nuclear-plastid interactions, plastome-encoded polypeptides and RNAs, as. Order cycloserine Fig. 1. Clinical picture of cancer cachexia. NSCLC: non-small cell lung cancer and cyclosporine. Human diseases iii and managed care is cycloserine good, according.

Therefore, resistance to both these drugs is a probability of the product or 10-16. Patients with extensive tuberculosis cavitary lesions harbour fewer bacteria than this so that spontaneous dual resistance is highly improbable. Probability of incidence of drug resistant mutants: Rifampicin -1 in 108 INH SM EMB -1 in 106 Natural Resistance to SM -10% Ethionamide ; Cycloserine ; 1 in 103 Thiacetazone ; Capreomycin, Viomycin, Enviomycin. ; It has recently been observed that transmission of MDR strains of M tuberculosis may break the natural model described and may promote development of mutation and lead to resistance. It may promote selective proliferation of pre-existing mutation. Organism may become resistant to single or multiple drugs. The emergence of acquired drug resistance is primarily due to inaccurate application of regimes. Omission of one or more drugs or monotherapy, sub-optimal doses of the drugs, poor drug absorption or insufficient number of active agents in the regimen leads to conversion of a susceptible strain of M. tuberculosis to resistance to one or multiple drugs within a span of a few months. Acquired drug resistance may be caused due to selection of pre-existing mutants and their eventual proliferation because of inaccurate chemotherapy and cylert.
42 If the periodograms of K segments are averaged, the estimate is called a Bartlett averaged periodogram. It should be noted here that the periodogram is only one way of estimating the spectrum of the process, and is by no means a "definition" of the spectrum. Modifications of the averaged periodogram also exist, among which the Welch periodogram is introduced. In this method, data segments are allowed to overlap by 50% or 70%, for example, and each data segment will be weighted with a window function before calculating the periodogram. As a result, one has for the periodogram of each segment ~p Px. Sales of ARTZ products in Japan have been affected by increased use of generic products and reductions in NHI drug prices. On the other hand, the majority of patients for joint improver formulations are elderly, and because this age group is growing in the population, the market in Japan expanded at 4.9% compared with the previous fiscal year. In view of these circumstances, we plan to work closely with Kaken Pharmaceutical Co., Ltd. to promote our products on the basis of our high standards of quality and safety. A key advantage will be the status of our products as frontrunners trusted by the medical community, with the longest sales track record and highest sales in Japan in their class. We will also strive to differentiate our products and maintain sales through determined efforts on various levels, including the expansion our scientific information dissemination activities. The Japanese market for our other major product, OPEGAN and OPEGAN Hi, the ophthalmic surgical aid for cataract surgery, is affected by limits on the number of units per operation, increased use of larger units, and slower growth in the number of cataract operations. However, we expect sales volumes to grow in step with growth of the aged population. We will work even more closely with Santen Pharmaceutical Co., Ltd. to enhance the potential of OPEGAN products and strengthen sales support. Our assets in this area include reliable quality, and an effective approach to user needs, based on the flexibility that is possible because OPEGAN is made in Japan and cytarabine.

MATERIALS AND METHODS Bacterial strains. Five new strains were studied. Two of these strains strains 938T [T type strain] and 1336 ; were received in 1987 from the Hospital Cantoblanco in Madrid, Spain; two strains 1635 and 1636 ; were received from the same hospital in 1989; and one strain 1470 ; was received in 1987 from the Hospital Santa Marina in Pais Vasco, Spain. All of the strains were recovered from sputum specimens from different patients. In addition, we studied the following previously described mycobacterial strains: Mycobacterium abscessus ATCC 19977T American Type Culture Collection ; , Mycobacterium agri CIPT 1320001T Collection Institut Pasteur Tuberculose ; , Mycobacterium aurum L1 11 ; , Mycobacterium brumae CIPT 103465T, Mycobacterium chelonae ATCC 35752T, Mycobacterium chitae CIPT 116000, Mycobacterium fortuitum ATCC 6841T, Mycobacterium gadium ATCC 27726T, Mycobacterium gilvum Standford 132, Mycobacterium mucogenicum 283 laboratory-isolated strain ; , Mycobacterium peregrinum ATCC 14467T, Mycobacterium phlei IMRU 500 Institute of Microbiology, Rutgers University ; , Mycobacterium porcinum ATCC 27406T, Mycobacterium senegalense NCTC 10956T National Collection of Type Cultures ; , and Mycobacterium smegmatis CIPT 141330010T. Nocardia asteroides Centro Nacional de Microbiologia Virologia e Inmunologia Sanitarias ; was also studied. Characterization of strains. Standard methods were used to isolate mycobacteria from clinical specimens 24 ; . Colony morphology and the ability to grow at various temperatures 22, 30, 37, and 45 C ; , pigment production, and photoreactivity were determined after 2 weeks of incubation on Lowenstein-Jensen slants. The following properties were determined as described previously: nitrate reductase, arylsulfatase, urease, nicotinamidase, pyrazinamidase, allantoinase, benzamidase, iso-nicotinamidase, succinamidase 32 ; , and catalase 34 ; activities, resistance to sodium chloride, and hydrolysis of Tween 80 33 ; . Tests to determine iron uptake and utilization of citrate, mannitol, and inositol as sole carbon sources were performed by using the procedure of Silcox et al. 23 ; . Growth in the presence of isoniazid 0.2 and 1.0 g ml ; , ethambutol 1.5 and 2.0 g ml ; , cycloserine 30 and 40 g ml ; , capreomycin 40 g ml ; , thiosemicarbazone 20 g ml ; , and thiophen-2-carboxylic acid hydrazide 10 g ml ; was determined as described previously 6 ; . Analyses of mycolic acids were performed by one-dimensional thin-layer chromatography as described previously 2 ; . Catalase activity gels. The protein extracts used for nondenaturing polyacrylamide gel electrophoresis ND-PAGE ; on 10% wt vol ; polyacrylamide gels were prepared as described previously 4, 37 ; . The catalase and peroxidase activities of mycobacterial extracts were examined by the double-staining method as described previously 35 ; . Thermolabile and thermostable enzymes were distinguished by heat treating extracts at 68 C for 1 min before the ND-PAGE gels were electrophoresed. DNA extraction. Bacterial strains were grown in 100-ml Dubos-Tween-albumin DTA ; broth Difco Laboratories ; cultures. Extraction and purification of DNA were carried out as described previously 9 ; . Briefly, cultures were incubated with D-cycloserine for 24 to 48 Cells were then lysed with lysozyme 4 mg ml ; , proteinase K 50 g and sodium dodecyl sulfate 1% ; , and the extracts were purified by phenol-chloroform and ethanol precipitation. DNA concentrations were estimated by UV absorbance, and then the preparations were stored in ethanol at 20 C. Nucleic acid analysis. i ; PCR-RFLP analysis of the heat shock protein gene hsp65 ; . A two-step assay in which a PCR was followed by a restriction fragment length polymorphism RFLP ; analysis was used to compare our strains with other rapidly growing mycobacterial species, as described by Telenti et al. 31 ; . Amplified products were digested with restriction enzymes BstEII and HaeIII Boehringer-Mannheim ; in separate reactions and then were separated by horizontal electrophoresis by using NuSieve agarose FMC Bioproducts ; gels. Fragments were visualized by ethidium bromide staining and exposure to UV light.
Resistance to isoniazid, rifampicin, ethambutol with or without resistance to streptomycin ; During the initial phase, use ethionamide plus ofloxacin plus another bacteriostatic drug cycloserine or PAS ; with pyrazinamide and an aminoglycoside available for a minimum of 3 months or until smear conversion. During the continuation phase, use ethionamide plus ofloxacin plus cycloserine or PAS ; for at least 18 months after smear conversion Table 7 and cytomel.
Gamma production in relapsing-remitting multiple sclerosis. Neurology 1994; 44: 40613. Ebers GC, Koopman WJ, Hader W, Sadovnick AD, Kremenchutzky M, Mandalfino P, et al. The natural history of multiple sclerosis: a geographically based study: 8. Familial multiple sclerosis. Brain 2000; 123: 6419. European Study Group. Placebo-controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis. European Study Group on interferon beta-1b in secondary progressive multiple sclerosis. Lancet 1998; 352: 14917. Ferguson B, Matyszak MK, Esiri MM, Perry VH. Axonal damage in acute multiple sclerosis lesions. Brain 1997; 120: 3939. Fog T. Topographic distribution of plaques in the spinal cord in multiple sclerosis. Arch Neurol 1950; 63: 382414. Hader WJ, Elliot M, Ebers GC. Epidemiology of multiple sclerosis in London and Middlesex County, Ontario, Canada. Neurology 1988; 38: 61721. Hawkins SA, McDonnell GV. Benign multiple sclerosis? Clinical course, longterm follow up, and assessment of prognostic factors. J Neurol Neurosurg Psychiatry 1999; 67: 14852. INFB multiple sclerosis Study Group. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group. Neurology 1993; 43: 65561. INFB Multiple Sclerosis Study Group. Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. The IFNB Multiple Sclerosis Study Group and The University of British Columbia Multiple Sclerosis MRI Analysis Group. Neurology 1995; 45: 127785. Jacobs LD, Cookfair DL, Rudick RA , Herndon RM, Richert JR, Salazar AM, et al. Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group MSCRG ; . Ann Neurol 1996; 39: 28594. Johnson KP, Brooks BR, Cohen JA, Ford CC, Goldstein J, Lisak RP, et al. Copolymer 1 reduces relapse rate and improves disability in relapsingremitting multiple sclerosis: results of a phase III multicenter, doubleblind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group. Neurology 1995; 45: 126876. Koch-Henriksen N. The Danish Multiple Sclerosis Registry: a 50-year followup. Mult Scler 1999; 5: 2936. Kremenchutzky M, Cottrell D, Rice G, Hader W, Baskerville J, Koopman W, et al. The natural history of multiple sclerosis: a geographically based study. 7. Progressive-relapsing and relapsing-progressive multiple sclerosis: a reevaluation. Brain 1999; 122: 194150. Kurtzke JF. On the evaluation of disability in multiple sclerosis. Neurology 1961; 11: 68694. Kurtzke JF, Beebe GW, Nagler B, Kurland LT, Auth TL. Studies on the natural history of multiple sclerosis. 8. Early prognostic features of the later course of the illness. J Chronic Dis 1977; 30: 81930. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale EDSS ; . Neurology 1983; 33: 144452. Lassmann H. Comparative neuropathology of chronic experimental allergic encephalomyelitis and multiple sclerosis. Schriftenr Neurol 1983; 25: 1135. Leibowitz U, Alter M. Clinical factors associated with increased disability in multiple sclerosis. Acta Neurol Scand 1970; 46: 5370. Liu C, Blumhardt LD. Disability outcome measures in therapeutic trials of relapsing-remitting multiple sclerosis: effects of heterogeneity of disease course in placebo cohorts. J Neurol Neurosurg Psychiatry 2000; 68: 4507. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society USA ; Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 1996; 46: 90711. Lumsden CE. The neuropathology of multiple sclerosis. In: Vinken PJ, Bruyn GW, editors. Handbook of clinical neurology. Amsterdam: Elsevier; 1970: 217309. Lynn AH, Kwoh CK, Venglish CM, Aston CE, Chakravarti A. Genetic epidemiology of rheumatoid arthritis. J Hum Genet 1995; 57: 1509.
1951. 18 MARSHAK, A.: "Differences in Response of Virulent Strain of Tubercle Bacillus and Its , virulent Variant to Metabolites and Their Genetic Significance, " . Bact., 61: 1, 1951. SCHAEFER, W. B.: "The Effect of Isoniazid on Growing and Resting Tubercie Bacilli, " Am. Rev. Tuberc., 69: 125, 1954. KOC51-WESER, D., BARCLAY, W. R., AND EuERT, R. H.: "The Influence of Isoniazid and Streptomycin on Acid-Fastness, Tetrazolium Reduction, Growth, and Survival of Tubercle Bacilli, " Am. Rev. Tuberc., 71: 556, 1955. BARCLAY, W. R., AND RUSSE, H.: "The In Vitro Action of Cycloserine on M. Tuberculosis, " Am. Rev. Tuberc., 72: 236, 1955. DUNBAR, J. M.: "L'apparition de Formes Non Acido-Resistantes de Mycobacterium Tuberculosis en Presence D'isoniazide, de Cycloserine et du Thioamide de L'acide a-Ethyl Iso-Nicotique, " Ann. Inst. Pasteur Par. ; , 92: 451, 1957. S, M. S.: "Preliminary Observations on and cytoxan.
Three alternative prayers are given here. The third alternative is used if the prayer of intercession has been omitted earlier in the service # 10.

Annexe au E Doc. 41.690 Annex to SCS 13 dc. 97 ; SSC 13 Dec. 97 ; Direction de la nomenclature et de la classification Director Directeur Mr. I. KUSAHARA Deputy Director Directeur adjoint Mr. N. SASIDHARAN Senior Technical Officer Supervisor ; Administrateur technique principal cadre ; M. L. FORNSTER Senior Technical Officers Administrateurs techniques principaux Mr. D. BECK Mr. J. HINDSDAL Technical Officers Administrateurs techniques M. G. BORSU Mr. S. KOCAS Technical Attachs Attachs techniques Mr. K. OMOTO Mr. N. YAHABA Interpreters Interprtes M. L. BELLAGAMBA M. G. GILLOT Mme P. MANIN.

The risk of seizures may be increased when ethionamide is used in combination with cycloserine seromycin ; or isoniazid nydrazid and damiana.

T is time to admit that we need a two pronged approach to equity in health: a scientific and a policy effort. These may not be synchronised and each has to be allowed to run its own course, but they need to happen simultaneously. On the one hand we are confronted with a teasing scientific problem. Why are social inequalities in health so universal? They show a clear gradient for almost any health indicator by any measure of social position--be it education, income, professional class, or social class--in every country where data have been collected, irrespective of the country's position on income distribution, access to education, regulations on working conditions, social benefits, or social housing policies. Why do health inequalities appear to affect almost all diseases, both the diseases of poverty and the lifestyle related diseases of more affluent societies? Through which more proximal risk factors do socioeconomic factors affect the occurrence and pathophysiology of individual diseases? And what do we know about the lag times between exposure and outcomes? We do not accept mere correlations of time series as sufficient evidence of causation in other areas of epidemiology, so why here? When we see the strength of the relation diminish with old age, is that an. Conductive keratoplasty CK ; is a non-ablative, collagen shrinking procedure.As opposed to LTK which is laser based, CK is based on the delivery of radiofrequency energy through a fine conducting tip inserted into the peripheral corneal stroma. Because of its electrolytic properties, the cornea conducts radiofrequency energy.As the current flows through the tissue surrounding the tip, resistance to the current creates localized heat. Collagen lamellae in the area surrounding the tip shrink in a controlled fashion and form a column of denatured collagen. The ViewPointTM CK system for performing conductive keratoplasty consists of a portable console, a lid speculum that acts as the electrical return path, and a hand-piece that holds the 450 m long and 90 m wide metal tip KeratoplastTM Tip ; . For hyperopia treatment, the surgeon inserts the tip into the stroma at defined spots in a ring pattern around the peripheral cornea according to the supplied nomogram.The number and location of spots determines the amount of refractive change, with an increasing number of spots and rings used for higher amounts of hyperopia. Conductive keratoplasty and LTK differ in several respects. In LTK, heat is applied directly to the corneal surface, resulting in a thermal gradient in which the treatment is hotter at the surface and cooler in the deeper stroma.The resulting footprint of denatured collagen is conical, wider on the surface and tapering in the stroma. CK-treated tissue is exposed to the same temperature at the tip of the probe deep in the stroma ; as at the top of the probe the corneal surface ; . Confocal microscopy and histology show a deep approximately 80% of the corneal depth ; , cylindrical footprint. Histologic studies of the pig cornea show confirms that the footprint made by CK is cylindrical and extends deep into the stroma. Striae form between the treated spots, creating a band of tightening that increases the curvature of the central cornea. The deeper more consistent collagen shrinkage with CK is expected to produce a more stable effect. CK appears to have advantages both in initial cost and flexible off-label ; treatment patterns. Since the tip can be placed anywhere in the cornea, CK may be useful for treating astigmatism after LASIK or cataract surgery, replacing incisional enhancement procedures, such as astigmatism keratectomy or limbal relaxing incisions.When used to correct astigmatism, the surgeon must customise the procedure and apply selected spots to steepen the necessary axis. Treatment can be performed at the slit-lamp in a standard examination room instead of a surgical suite.

The brands listed above are not to be considered an endorsement. They are only used as examples of eligible products reimbursable under your Medical Expense FSA. 130. Ferris S, Lucca U, Mohs R, et al. Objective psychometric tests in clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. Alzheimer Dis Assoc Disord. 1997; 11 suppl 3 ; : 34-38. 131. Allain H, Wesnes KA, Neuman E, et al. Acceptability and clinical activity of 4 weeks treatment by S 12024-2 in 53 in-patients with moderate-tosevere Alzheimer's disease. Neurobiol Aging. 1994; 15: S136-S137. 131. Fakouhi TD, Jhee SS, Sramek JJ, et al. Evaluation of cycloserine in the treatment of Alzheimer's disease. J Geriatr Psychiatry Neurol. 1995; 8: 226-230. Mohr E, Knott V, Sampson M, Wesnes KA, Herting R, Mendis T. Cognitive and quantified electroencephalographic correlates of cycloserine treatment in Alzheimer's disease. Clin Neuropsychopharmacol. 1995; 18: 23-38. Wesnes KA, Scott M, Boyle M, Surmon DJ, Wilcock GK. Use of the Cognitive Drug Research computerized assessment system to measure the efficacy of THA and galanthamine in Alzheimer's disease. Psychopharmacol Bull. 1994; 30: 139. Siegfried K. A placebo-controlled crossover study of velnacrine in patients with Alzheimer's disease. Neurology. 1992; 42 suppl 3 ; : 141. 136. Wesnes KA, Scott M, Morrison S, Greenwood D, Russell-Duff K, Wilcock GK. The effects of galanthamine on attention in Alzheimer's disease. J Psychopharmacol. 1998; 12 suppl A ; : A46. 137. Ayre G, Ballard C, Pincock C, McKeith I, Sahgal A, Wesnes KA. Double dissociation between dementia with Lewy bodies and Alzheimer's disease on tests of attentional and mnemonic function: the role of the basal forebrain. J Psychopharmacol. 1998; 12 suppl A ; : A41. 138. Ayre GA, Sahgal A, McKeith IG, et al. Distinct profiles of neuropsychological impairment in dementia with Lewy bodies and Alzheimer's disease. Neurology. 2000. In press. 139. Ayre G, McKeith IG, Sahgal A, Ballard CG, Wesnes KA. The profile of cognitive deterioration in Lewy body dementia. Proc Br Psychol Soc. 1997; 5: 48. McKeith IG, Ayre GA, Pincock C, et al. The relative impairment of attentional and secondary memory function distinguishes dementia with Lewy bodies and Alzheimer's disease. Neurobiol Aging. 1998; 19 suppl 2 ; : S206. 141. Papka M, Schiffer R, Valone C. A prospective study of Lewy body disease. J Neuropsychiatry Clin Neurosci. 1999; 11: 141-142. Ayre GA, McKeith IG, Sahgal A, Ballard CG, Wesnes KA. Dementia with Lewy bodies, Alzheimer's disease and vascular dementia show distinct patterns of cognitive impairment. J Psychopharmacol. 1997; 11 suppl ; : A56. 143. Ayre G, Ballard C, Pincock C, Wesnes KA, McKeith I, Sahgal A. Association between visual hallucinations, neurochemical pathology and cognition in dementia with Lewy bodies. J Psychopharmacol. 1998; 12 suppl A ; : A64. 144. Walker MP, Ayre GA, Ashton CH, et al. A psychophysiological investigation of fluctuating consciousness in neurodegenerative dementias. Hum Psychopharmacol. 1999; 14: 483-489. Wesnes KA. Predicting, assessing, differentiating and treating the dementias: experience in MCI and various dementias using the CDR computerized cognitive assessment system. In: Vellas B, Fitten LJ, eds. Research and Practice in Alzheimer's disease. Vol 3. Paris, France: Serdi 2000: 59-65. 146. Hunter R, Cameron S, Perks S, Wesnes KA. The cognitive profile of unmedicated schizophrenic patients in relation to controls. J Psychopharmacol. 1997; 11 suppl ; : A74. 147. Scholey A, McCue P, Wesnes KA. A comparison of the cognitive deficits seen in myalgic encephalomyelitis to Alzheimer's disease. Proc Br Psychol Soc. 1999; 7: 12. Black K, Scholey A, Ayre GA, Wesnes KA. A computerized cognitive assessment of multiple sclerosis. Proc Br Psychol Soc. 1999; 7: 119. Scholey AB, Black K, Ayre GA, Wesnes KA. Cognitive deficits in multiple sclerosis: a computerized assessment. J Psychopharmacol. 1999; 13 suppl A ; : A29. 150. Roberts N, Pincock C, Wesnes KA. Some cognitive effects of hyperthyroidism. J Psychopharmacol. 1997; 11 suppl ; : A61. 151. Parry SW, McCue P, Ayre GA, Stout NR, Wesnes KA, Kenny RA. Cognition is impaired in elderly fallers with carotid sinus syndrome CSS ; . J Psychopharmacol. 1999; 13 suppl A ; : A29. Surgical excision; very resistant to drugs--INH, rifampin, streptomycin + cycloserine rare in U.S and cyclosporine.